Not applicableStudy completedNCT04856540What this trial is testingAdult Outcomes of Children With CAPSWho this might be right forCryopyrin Associated Periodic Syndrome University Hospital, Lille 54
Large-scale testing (Phase 3)Ended earlyNCT00770601What this trial is testingCanakinumab to Treat Neonatal-Onset Multisystem Inflammatory DiseaseWho this might be right forNOMIDCINCA Syndrome Novartis Pharmaceuticals 7
Not applicableNot Yet RecruitingNCT06544018What this trial is testingCircadian Rhythm Deregulation in Patients With CAPSWho this might be right forCryopyrin Associated Periodic SyndromeFamilial Cold UrticariaMuckle-Wells Syndrome+1 more Hospices Civils de Lyon 30
Large-scale testing (Phase 3)Study completedNCT00991146What this trial is testingEfficacy and Safety Study of Canakinumab Administered for 6 Months (24 Weeks) in Japanese Patients With Cryopyrin-associated Periodic Syndromes Followed by an Extension PhaseWho this might be right forCryopyrin-associated Periodic SyndromesFamilial Cold Autoinflammatory SyndromeMuckle-Wells Syndrome+1 more Novartis Pharmaceuticals 19
Large-scale testing (Phase 3)Study completedNCT01302860What this trial is testingEfficacy, Safety and Tolerability of ACZ885 in Pediatric Patients With the Following Cryopyrin-associated Periodic Syndromes: Familial Cold Autoinflammatory Syndrome, Muckle-Wells Syndrome, or Neonatal Onset Multisystem Inflammatory DiseaseWho this might be right forCryopyrin-associated Periodic SyndromesFamilial Cold Autoinflammatory SyndromeMuckle-Wells Syndrome+1 more Novartis Pharmaceuticals 17
Early research (Phase 1)Looking for participantsNCT06974877What this trial is testingRepeat PET/CT Imaging in People With CAPS and Anakinra-Induced Amyloidosis Using an Amyloid-Reactive Peptide to Measure Changes in Organ-Specific Amyloid LoadWho this might be right forCryopyrin-Associated Periodic SyndromesAmyloidosis National Institute of Allergy and Infectious Diseases (NIAID) 30
Not applicableStudy completedNCT01213641What this trial is testingClinical Outcomes and Safety: A Registry Study of Ilaris (Canakinumab) PatientsWho this might be right forCryopyrin-associated Periodic Syndromes (CAPS)Familial Cold Autoinflam Syn (FCAS)Muckle-wells Syn (MWS)+1 more Novartis Pharmaceuticals 288
Testing effectiveness (Phase 2)Ended earlyNCT02853084What this trial is testingHL2351 CAPS Phase II StudyWho this might be right forCryopyrin-Associated Periodic Syndromes (CAPS) Handok Inc. 8
Testing effectiveness (Phase 2)Ended earlyNCT00069329What this trial is testingAnakinra to Treat Patients With Neonatal Onset Multisystem Inflammatory DiseaseWho this might be right forNervous System MalformationsArthropathy, NeurogenicUrticaria+1 more National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) 43
Large-scale testing (Phase 3)Study completedNCT01576367What this trial is testingEfficacy, Safety and Tolerability of ACZ885 in Pediatric Patients With the Following Cryopyrin-associated Periodic Syndromes: Familial Cold Autoinflammatory Syndrome, Muckle-Wells Syndrome, or Neonatal Onset Multisystem Inflammatory DiseaseWho this might be right forCryopyrin-associated Periodic SyndromesFamilial Cold Autoinflammatory SyndromeMuckle-Wells Syndrome+1 more Novartis Pharmaceuticals 17
Large-scale testing (Phase 3)Study completedNCT01105507What this trial is testingThe Safety and Efficacy of Canakinumab in Patients Aged 4 Years or Older Diagnosed With Cryopyrin-associated Periodic Syndromes (CAPS) in CanadaWho this might be right forCryopyrin Associated Periodic Syndrome Novartis Pharmaceuticals 4
Large-scale testing (Phase 3)Study completedNCT00685373What this trial is testingEfficacy and Safety of ACZ885 in Patients With the Following Cryopyrin-associated Periodic Syndromes: Familial Cold Autoinflammatory Syndrome, Muckle-Wells Syndrome, or Neonatal Onset Multisystem Inflammatory DiseaseWho this might be right forCryopyrin-Associated Periodic SyndromesFamilial Cold Autoinflammatory SyndromeMuckle Wells Syndrome+1 more Novartis 166